| XLS |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
Equity capital |
Reserves |
Gains/losses recognized |
|
|
| |||||||
|
€ million |
General |
Subscribed |
Capital |
Retained |
Remea- |
Available- |
Derivative |
Currency |
Equity |
Non-con- |
Equity | ||
| |||||||||||||
|
Balance as of January 1, 2011 |
397.2 |
168.0 |
3,813.7 |
5,040.9 |
–370.4 |
–3.1 |
–61.1 |
1,344.6 |
10,329.8 |
42.0 |
10,371.8 | ||
|
Adjustment IAS 19 |
– |
– |
– |
–0.6 |
5.4 |
– |
– |
– |
4.8 |
– |
4.8 | ||
|
Balance as of January 1, 2011 adjusted |
397.2 |
168.0 |
3,813.7 |
5,040.3 |
–365.0 |
–3.1 |
–61.1 |
1,344.6 |
10,334.6 |
42.0 |
10,376.6 | ||
|
Profit after tax* |
– |
– |
– |
249.7 |
– |
– |
– |
– |
249.7 |
5.0 |
254.7 | ||
|
Gains/losses recognized immediately in equity* |
– |
– |
– |
– |
2.1 |
2.7 |
9.4 |
–35.7 |
–21.5 |
–3.2 |
–24.7 | ||
|
Comprehensive income* |
– |
– |
– |
249.7 |
2.1 |
2.7 |
9.4 |
–35.7 |
228.2 |
1.8 |
230.0 | ||
|
Dividend payments |
– |
– |
– |
–80.8 |
– |
– |
– |
– |
–80.8 |
–3.4 |
–84.1 | ||
|
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–166.6 |
– |
– |
– |
– |
–166.6 |
– |
–166.6 | ||
|
Changes in scope of consolidation/ Other |
– |
– |
– |
–1.7 |
– |
– |
– |
– |
–1.7 |
1.3 |
–0.4 | ||
|
Balance as of June 30, 2011* |
397.2 |
168.0 |
3,813.7 |
5,040.9 |
–362.9 |
–0.4 |
–51.7 |
1,308.9 |
10,313.7 |
41.7 |
10,355.4 | ||
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Balance as of January 1, 2012 |
397.2 |
168.0 |
3,813.7 |
5,248.7 |
–390.7 |
0.8 |
–94.6 |
1,304.0 |
10,447.1 |
46.3 |
10,493.4 | ||
|
Adjustment IAS 19 |
– |
– |
– |
–11.6 |
12.5 |
– |
– |
– |
0.9 |
– |
0.9 | ||
|
Balance as of January 1, 2012 adjusted |
397.2 |
168.0 |
3,813.7 |
5,237.1 |
–378.2 |
0.8 |
–94.6 |
1,304.0 |
10,448.0 |
46.3 |
10,494.3 | ||
|
Profit after tax |
– |
– |
– |
109.5 |
– |
– |
– |
– |
109.5 |
5.1 |
114.6 | ||
|
Gains/losses recognized immediately in equity |
– |
– |
– |
– |
–11.7 |
0.1 |
4.5 |
43.1 |
36.0 |
–1.1 |
34.9 | ||
|
Comprehensive income |
– |
– |
– |
109.5 |
–11.7 |
0.1 |
4.5 |
43.1 |
145.5 |
4.0 |
149.5 | ||
|
Dividend payments |
– |
– |
– |
–96.9 |
– |
– |
– |
– |
–96.9 |
–4.9 |
–101.8 | ||
|
Profit transfers to/from E. Merck KG including transfers to reserves |
– |
– |
– |
–8.5 |
– |
– |
– |
– |
–8.5 |
– |
–8.5 | ||
|
Changes in scope of consolidation/ Other |
– |
– |
– |
–3.1 |
– |
– |
– |
– |
–3.1 |
3.3 |
0.2 | ||
|
Balance as of June 30, 2012 |
397.2 |
168.0 |
3,813.7 |
5,238.1 |
–389.9 |
0.9 |
–90.1 |
1,347.1 |
10,485.0 |
48.7 |
10,533.7 | ||
